c-Myc Inhibits Macrophage Antimycobacterial Response in Mycobacterium tuberculosis Infection.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 40884499.
- Also identified by DOI 10.1093/infdis/jiaf456 and PMC identifier 12526935.
- Licence recorded as CC BY-NC-ND.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Mycobacterium tuberculosis (MTB) remains a major cause of global mortality, yet natural immunity prevents disease in more than 90% of exposed individuals. Interferon gamma (IFN-γ) is a critical regulator of innate immunity and enhances macrophage antimicrobial responses. Using in vitro systems approaches, we compared the effects of IFN-γ exposure before versus after infection. We manipulated c-Myc in primary macrophages with a tetracycline-inducible lentiviral system. c-Myc expression was also analyzed in tissues from murine tuberculosis models and human granulomas. Preinfection IFN-γ exposure primed macrophages for enhanced bacterial control, whereas postinfection exposure did not. We identified c-Myc signaling as a central determinant of macrophage antimycobacterial function. Inhibition of c-Myc via Omomyc enhanced bacterial control partly through mTORC1-dependent metabolic reprogramming and nitric oxide production. In vivo analyses, including murine models and human clinical histopathology, revealed strong associations between c-Myc expression, MTB persistence, and active tuberculosis. c-Myc mediates immune privilege in MTB infection and represents a promising target for host-directed therapies to enhance macrophage function.
Medical subject headings
- Macrophages
- Mycobacterium tuberculosis
- Tuberculosis
- Proto-Oncogene Proteins c-myc